Patent 7968702 was granted and assigned to Pacific Biosciences on June, 2011 by the United States Patent and Trademark Office.
Labeled reactant compositions, and particularly labeled nucleic acid reaction compositions, that include structural components that maintain potentially damaging labeling components sufficiently distal from the reactant portion of the molecule such that damaging effects of the label group on other reaction components, such as enzymes, are reduced, minimized and/or eliminated.